Marion Odence-Ford - Feb 11, 2022 Form 4 Insider Report for OptimizeRx Corp (OPRX)

Role
General Counsel and CCO
Signature
/s/ Marion Odence-Ford
Stock symbol
OPRX
Transactions as of
Feb 11, 2022
Transactions value $
$0
Form type
4
Date filed
2/15/2022, 03:45 PM
Previous filing
Nov 10, 2021
Next filing
Mar 3, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OPRX Common Stock Options Exercise +4K 4K Feb 11, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OPRX Restricted Stock Units Options Exercise $0 -4K -20% $0.00 16K Feb 11, 2022 Common Stock 4K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units convert into common stock on a one-for-one basis.
F2 On February 11, 2021, the reporting person was granted 20,000 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date

Remarks:

The filing of this Statement shall not be construed as an admission (a) that the person filing this Statement is, for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the beneficial owner of any equity securities covered by this Statement, or (b) that this Statement is legally required to be filed by such person.